Alzheimer's disease: An inflammatory disease?

被引：28

作者：

Fassbender, K

Masters, C

Beyreuther, K

机构：

[1] Univ Heidelberg, Univ Clin Mannheim, Dept Neurol, D-68135 Mannheim, Germany

[2] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia

[3] Univ Heidelberg, ZMBH, Ctr Mol Biol, D-6900 Heidelberg, Germany

来源：

NEUROBIOLOGY OF AGING | 2000年 / 21卷 / 03期

关键词：

D O I：

10.1016/S0197-4580(00)00147-0

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：433 / 436

页数：4

共 24 条

[1] TUMOR-NECROSIS-FACTOR-ALPHA AND TUMOR-NECROSIS-FACTOR-BETA PROTECT NEURONS AGAINST AMYLOID BETA-PEPTIDE TOXICITY - EVIDENCE FOR INVOLVEMENT OF A KAPPA-B-BINDING FACTOR AND ATTENUATION OF PEROXIDE AND CA2+ ACCUMULATION [J].

BARGER, SW ;

HORSTER, D ;

FURUKAWA, K ;

GOODMAN, Y ;

KRIEGLSTEIN, J ;

MATTSON, MP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9328-9332

[2] TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs [J].

Blasko, I ;

Marx, F ;

Steiner, E ;

Hartmann, T ;

Grubeck-Loebenstein, B .

FASEB JOURNAL, 1999, 13 (01) :63-68

[3] CHOLINERGIC AGONISTS AND INTERLEUKIN-1 REGULATE PROCESSING AND SECRETION OF THE ALZHEIMER BETA/A4 AMYLOID PROTEIN-PRECURSOR [J].

BUXBAUM, JD ;

OISHI, M ;

CHEN, HI ;

PINKASKRAMARSKI, R ;

JAFFE, EA ;

GANDY, SE ;

GREENGARD, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10075-10078

[4]

Castillo GM, 1997, J NEUROCHEM, V69, P2452

[5] IMMUNOGLOBULINS AND COMPLEMENT FACTORS IN SENILE PLAQUES - AN IMMUNOPEROXIDASE STUDY [J].

EIKELENBOOM, P ;

STAM, FC .

ACTA NEUROPATHOLOGICA, 1982, 57 (2-3) :239-242

[6]

ElKhoury J, 1996, NATURE, V382, P716

[7] THE US ECONOMIC AND SOCIAL COSTS OF ALZHEIMERS-DISEASE REVISITED [J].

ERNST, RL ;

HAY, JW .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (08) :1261-1264

[8] ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN [J].

GAMES, D ;

ADAMS, D ;

ALESSANDRINI, R ;

BARBOUR, R ;

BERTHELETTE, P ;

BLACKWELL, C ;

CARR, T ;

CLEMENS, J ;

DONALDSON, T ;

GILLESPIE, F ;

GUIDO, T ;

HAGOPIAN, S ;

JOHNSONWOOD, K ;

KHAN, K ;

LEE, M ;

LEIBOWITZ, P ;

LIEBERBURG, I ;

LITTLE, S ;

MASLIAH, E ;

MCCONLOGUE, L ;

MONTOYAZAVALA, M ;

MUCKE, L ;

PAGANINI, L ;

PENNIMAN, E ;

POWER, M ;

SCHENK, D ;

SEUBERT, P ;

SNYDER, B ;

SORIANO, F ;

TAN, H ;

VITALE, J ;

WADSWORTH, S ;

WOLOZIN, B ;

ZHAO, J .

NATURE, 1995, 373 (6514) :523-527

[9]

GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276

[10] Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS [J].

Hauss-Wegrzyniak, B ;

Willard, LB ;

Del Soldato, P ;

Pepeu, G ;

Wenk, GL .

BRAIN RESEARCH, 1999, 815 (01) :36-43

← 1 2 3 →